A review of the epidemiologic evidence concerning the reproductive health effects of caffeine consumption: A 2000-2009 update

Food and Chemical Toxicology

Volumn 48, Issue 10, 2010, Pages 2549-2576

  Peck, Jennifer David ^a   Leviton, Alan ^b   Cowan, Linda D ^a  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Birth defects; Caffeine; Fetal growth; Pregnancy outcomes; Reproduction; Spontaneous abortion

Indexed keywords

CAFFEINE;

CASE CONTROL STUDY; CONGENITAL MALFORMATION; EPIDEMIOLOGICAL DATA; FETUS DEATH; FOOD INTAKE; GESTATIONAL AGE; HUMAN; INFERTILITY; INFERTILITY THERAPY; INTRAUTERINE GROWTH RETARDATION; KARYOTYPE; METABOLISM; PREGNANCY; PREMATURITY; RECURRENT ABORTION; REPRODUCTIVE HEALTH; REVIEW; SELF REPORT; SMOKING; SPONTANEOUS ABORTION;

ABNORMALITIES, DRUG-INDUCED; ABORTION, SPONTANEOUS; CAFFEINE; CENTRAL NERVOUS SYSTEM STIMULANTS; FEMALE; FERTILITY; FETAL DEATH; FETAL GROWTH RETARDATION; HUMANS; INFERTILITY; OBSTETRIC LABOR, PREMATURE; PREGNANCY; REPRODUCTION; SMOKING;

EID: 77956340699     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2010.06.019     Document Type: Review

References (149)

1. Adeney K.L., Wiliams M.A., Schiff M.A., Chunfang Q., Sorensen T.K. Coffee consumption and risk of gestational diabetes. Acta Obstet. Gynecol. Scand. 2007, 86:161-166.
2. Aldridge A., Bailey J., Neims A.H. The disposition of caffeine during and after pregnancy. Semin. Perinatol. 1981, 5:310-314.
3. Arnaud M.J. Metabolism of caffeine and other components of coffee. Caffeine, Coffee and Health 1994, 43-95. Raven Press, New York. S. Garattini (Ed.).
4. Baird D.D., Wilcox A.J., Weinberg C.R. Use of time to pregnancy to study environmental exposures. Am. J. Epidemiol. 1986, 124:470-480.
5. Balat O., Balat A., Ugur M.G., Pençe S. The effect of smoking and caffeine on the fetus and placenta in pregnancy. Clin. Exp. Obstet. Gynecol. 2003, 30:57-59.
6. Ballard J.L., Novak K.K., Driver M.A. A simplified score for assessment of fetal maturation of newly born infants. J. Pediatr. 1979, 95:769-774.
7. Ballard J.L., Khoury J.C., Wedig K., Wang L., Eilers-Walsman B.L., Lipp R. New Ballard Score, expanded to include extremely premature infants. J. Pediatr. 1991, 119:417-423.
8. Barone J.J., Roberts H.R. Caffeine consumption. Food Chem. Toxicol. 1996, 34:119-129.
9. Bech B.H., Nohr E.A., Vaeth M., Henriksen T.B., Olsen J. Coffee and fetal death, a cohort study with prospective data. Am. J. Epidemiol. 2005, 162:983-990.
10. Bech B.H., Autrup H., Nohr E.A., Henriksen T.B., Olsen J. Stillbirth and slow metabolizers of caffeine, comparison by genotypes. Int. J. Epidemiol. 2006, 35:948-953.
11. Bech B.H., Obel C., Henriksen T.B., Olsen J. Effect of reducing caffeine intake on birth weight and length of gestation, randomised controlled trial. BMJ 2007, 334:409-414.
12. Berhman, R.E., Butler, A.S. (Eds.), 2007. Preterm birth. Causes, Consequences, and Prevention. The National Academies Press, Washington, DC.
13. Bille C., Olsen J., Vach W., Knudsen V.K., Olsen S.F., Rasmussen K., Murray J.C., Andersen A.M., Christensen K. Oral clefts and life style factors - a case-cohort study based on prospective Danish data. Eur. J. Epidemiol. 2007, 22:173-181.
14. Boylan, S.M., Cade, J.E., Kirk, S.F.L., Greenwood, D.C., White, K.L.M., Shires, S., Simpson, N.A.B., Wild, C.P., Hay, A.W.M., 2008. Assessing caffeine exposure in pregnant women. Br. J. Nutr. 100, 875-872.
15. Bracken M.D., Triche E., Grosso L., Hellenbrand K., Belanger K., Leaderer B.P. Heterogeneity in assessing self-reports of caffeine exposure, implications for studies of health effects. Epidemiology 2002, 13:165-171.
16. Bracken M.B., Triche E.W., Belanger K., Hellenbrand K., Leaderer B.P. Association of maternal caffeine consumption with decrements in fetal growth. Am. J. Epidemiol. 2003, 157:456-466.
17. Browne M.L., Bell E.M., Druschel C.M., Gensburg L.J., Mitchell A.A., Lin A.E., Romitti P.A., Correa A. Maternal caffeine consumption and risk of cardiovascular malformations. Birth Defects Res. A Clin. Mol. Teratol. 2007, 79:533-543. National Birth Defects Prevention Study.
18. Bukowski, R., Smith, G.C., Malone, F.D., Ball, R.H., Nyberg, D.A., Comstock, C.H., Hankins, G.D., Berkowitz, R.L., Gross, S.J., Dugoff, L., Craigo, S.D., Timor-Tritsch, I.E., Carr, S.R., Wolfe, H.M., D'Alton, M.E. FASTER Research Consortium, 2007. Fetal growth in early pregnancy and risk of delivering low birth weight infant, prospective cohort study. BMJ 334, 836-840.
19. Burdi A.R., Faist K. Morphogenesis of the palate in normal human embryos with special emphasis on the mechanisms involved. Am. J. Anat. 1967, 120:149-160.
20. Campbell M.E., Grant D.M., Inaba T., Kalow W. Biotransformation of caffeine, paraxanthine, theophylline, and theobromine by polycyclic aromatic hydrocarbon-inducible cytochrome(s) in human liver microsomes. Drug Metab. Dispos. 1987, 15:237-249.
21. Campbell M.E., Spielberg S.P., Kalow W. A urinary metabolite ratio that reflects systemic caffeine clearance. Clin. Pharmacol. Ther. 1987, 42:157-165.
22. CARE Study Group, 2008. Maternal caffeine intake during pregnancy and risk of fetal growth restriction, a large prospective observational study. BMJ 337, a2332.
23. Carrillo J., Benitez J. Clinically significant pharmacokinetic interactions between dietary caffeine and medications. Clin. Pharmacokinet. 2000, 39:127-153.
24. Chavarro J.E., Rich-Edwards J.W., Rosner B.A., Willett W.C. Caffeinated and alcoholic beverage intake in relation to ovulatory disorder infertility. Epidemiology 2009, 20:374-381.
25. Chiaffarino F., Parazzini F., Chatenoud L., Ricci E., Tozzi L., Chiantera V., Maffioletti C., Fedele L. Coffee drinking and risk of preterm birth. Eur. J. Clin. Nutr. 2006, 60:610-613.
26. Clausson B., Granath F., Ekbom A., Lundgren S., Nordmark A., Signorello L.B., Cnattingius S. Effect of caffeine exposure during pregnancy on birth weight and gestational age. Am. J. Epidemiol. 2002, 155:429-436.
27. Cnattingius, S., 2004. The epidemiology of smoking during pregnancy, smoking prevalence, maternal characteristics, and pregnancy outcomes. Nicotine Tob. Res. 6 (Suppl. 2), S125-S140.
28. Cnattingius S., Signorello L.B., Anneren G., Clausson B., Ekbom A., Ljunger F., Blot W.J., McLaughlin J.K., Peterson G., Rane A., Granath F. Caffeine intake and the risk of first-trimester spontaneous abortion. N. Engl. J. Med. 2000, 343:1839-1845.
29. Cohn B.A., Overstreet J.W., Fogel R.J., Brazil C.K., Baird D.D., Cirillo P.M. Epidemiologic studies of human semen quality, considerations for study design. Am. J. Epidemiol. 2002, 55:664-671.
30. Cole D.C., Wainman B., Sanin L.H., Weber J.P., Muggah H., Ibrahim S. Environmental contaminant levels and fecundability among non-smoking couples. Reprod. Toxicol. 2006, 22:13-19.
31. Collier S.A., Browne M.L., Rasmussen S.A., Honein M.A. Maternal caffeine intake during pregnancy and orofacial clefts. Birth Defects Res. A Clin. Mol. Teratol. 2009, 85:842-849. the National Birth Defects Prevention Study.
32. Dales L.G., Ury H.K. An improper use of statistical significance testing in studying covariables. Int. J. Epidemiol. 1978, 7:373-375.
33. Diego M., Field T., Hernandez-Reif M., Vera Y., Gil K., Gonzalez-Garcia A. Caffeine use affects pregnancy outcome. J. Child Adolesc. Subst. Abuse 2007, 17:41-49.
34. Dubowitz L.M., Dubowitz V., Goldberg C. Clinical assessment of gestational age in the newborn infant. J. Pediatr. 1970, 77:1-10.
35. Ford R.P., Tappin D.M., Schluter P.J., Wild C.J. Smoking during pregnancy, how reliable are maternal self reports in New Zealand?. J. Epidemiol. Community Health 1997, 51:246-251.
36. Gadsby R., Barnie-Adshead A.M., Jagger C. A prospective study of nausea and vomiting during pregnancy. Br. J. Gen. Pract. 1993, 43:245-248.
37. Gardosi J. Customized growth curves. Clin. Obstet. Gynecol. 1997, 40:715-722.
38. Gardosi, J., 2006. New definition of small for gestational age based on fetal growth potential. Horm. Res. 65 (Suppl. 3), 15-18.
39. George L., Granath F., Johansson A.L.V., Olander B., Cnattingius S. Risks of repeated miscarriage. Paediat. Perinat. Epidemiol. 2006, 20:119-126.
40. Giannelli M., Doyle P., Roman E., Pelerin M., Hermon C. The effect of caffeine consumption and nausea on the risk of miscarriage. Paediatr. Perinat. Epidemiol. 2003, 7:316-323.
41. Greenland S., Gustafson P. Accounting for independent nondifferential misclassification does not increase certainty that an observed association is in the correct direction. Am. J. Epidemiol. 2006, 164:63-68.
42. Grosso L.M., Bracken M.B. Caffeine metabolism, genetics, and perinatal outcomes, a review of exposure assessment consideration during pregnancy. Ann. Epidemiol. 2005, 15:460-466.
43. Grosso L.M., Rosenberg K.D., Belanger K., Saftlas A.F., Leaderer B., Bracken M.B. Maternal caffeine intake and intrauterine growth retardation. Epidemiology 2001, 12:447-455.
44. Grosso L., Triche E., Bracken M.B. Regarding " An unexpected distribution of sodium concentration in serum specimens stored for more than 30years" Ann. Epidemiol. 2004, 14:77-78.
45. Grosso L.M., Triche E.W., Belanger K., Benowitz N.L., Holford T.R., Bracken M.B. Caffeine metabolites in umbilical cord blood, cytochrome P-450 1A2 activity, and intrauterine growth restriction. Am. J. Epidemiol. 2006, 163:1035-1041.
46. Hassan M.A., Killick S.R. Negative lifestyle is associated with a significant reduction in fecundity. Fertil. Steril. 2004, 81:384-392.
47. Haugen M., Meltzer H.M., Brantsaeter A.L., Mikkelsen T., Osterdal M.L., Alexander J., Olsen S.F., Bakketeig L. Mediterranean-type diet and risk of preterm birth among women in the Norwegian Mother and Child Cohort Study (MoBa), a prospective cohort study. Acta Obstet. Gynecol. Scand. 2008, 87:319-324.
48. Hook E.B. What kind of controls to use in case control studies of malformed infants, recall bias versus " teratogen specificity" bias. Teratology 2000, 61:325-326.
49. Horak S., Polanska J., Widlak P. Bulky DNA adducts in human sperm, relationship with fertility, semen quality, smoking, and environmental factors. Mutat. Res. 2003, 537:53-65.
50. Infante-Rivard C. Caffeine intake and small-for-gestational-age birth, modifying effects of xenobiotic-metabolising genes and smoking. Paediatr. Perinat. Epidemiol. 2007, 21:300-309.
51. Jensen T.K., Bonde D.P., Joffe M. The influence of occupational exposure on male reproductive function. Occup. Med. 2006, 56:544-553.
52. Joffe M., Villard L., Li A., Plowman R., Vessey M. Long-term recall of time-to-pregnancy. Fertil. Steril. 1993, 60:99-104.
53. Joffe, M., Key, J., Best, N., Keiding, N., Scheike, T., Jensen, T.K., 2005. Studying time to pregnancy by use of a retrospective design. Am. J. Epidemiol. 162, 115-124.
54. Johansen A.M.W., Wilcox A.J., Lie R.T., Andersen L.F., Drevon C.A. Maternal consumption of coffee and caffeine-containing beverages and oral clefts, a population-based case-control study in Norway. Am. J. Epidemiol. 2009, 169:1216-1222.
55. Joseph L., Gyorkos T.W., Coupal L. Bayesian estimation of disease prevalence and the parameters of diagnostic tests in the absence of a gold standard. Am. J. Epidemiol. 1995, 141:263-272.
56. Kalow W., Tange B.-K. Caffeine as a metabolic probe, exploration of the enzyme-inducing effect of cigarette smoking. Clin. Pharmacol. Ther. 1991, 49:44-48.
57. Karypidis A.H., Söderström T., Nordmark A., Granath F., Cnattingius S., Rane A. Association of cytochrome P450 1B1 polymorphism with first-trimester miscarriage. Fertil. Steril. 2006, 86:1498-1503.
58. Khoury M.J., Flanders W.D., James L.M., Erickson J.D. Human teratogens, prenatal mortality, and selection bias. Am. J. Epidemiol. 1989, 130:361-370.
59. Khoury J.C., Miodovnik M., Buncher C.R., Kalkwarf H., McElvy S., Khoury P.R., Sibai B. Consequences of smoking and caffeine consumption during pregnancy in women with type 1 diabetes. J. Matern. Fetal Neonatal Med. 2004, 15:44-50.
60. Killick S., Trussell J., Cleland K., Moreau C. Factors associated with subfertility among women attending an antenatal clinic in Hull. Hum. Fertil. 2009, 12:191-197.
61. Klebanoff M.A. Conceptualizing categories of preterm birth. Prenat. Neonatal Med. 1998, 3:13-15.
62. Klebanoff M.A., Longnecker M.P. Response to Letter by Grosso et al. Ann. Epidemiol. 2004, 14:79-80.
63. Klebanoff M.A., Shiono P.H. Top down, bottom up and inside out, reflections on preterm birth. Paediatr. Perinat. Epidemiol. 1995, 9:125-129.
64. Klebanoff M.A., Levine R.J., Clemens J.D., DerSimonian R., Wilkins D.G. Serum cotinine concentration and self-reported smoking during pregnancy. Am. J. Epidemiol. 1998, 148:259-262.
65. Klebanoff M.A., Levine R.J., Dersimonian R., Clemens J.D., Wilkins D.G. Serum caffeine and paraxanthine as markers for reported caffeine intake in pregnancy. Ann. Epidemiol. 1998, 8:107-111.
66. Klebanoff, M.A., Levine, R.L., Clemens, J.D., et al., 1999. Maternal serum paraxanthine, a caffeine metabolite, and the risk of spontaneous abortion. N. Engl. J. Med. 341, 1639-1644.
67. Klebanoff M.A., Levine R.J., Clemens J.D., Wilkins D.G. Maternal serum caffeine metabolites and small-for-gestational age birth. Am. J. Epidemiol. 2002, 155:32-37.
68. Klonoff-Cohen H., Bleha J., Lam-Kruglick P. A prospective study of the effects of female and male caffeine consumption on the reproductive endpoints of IVF and gamete intra-fallopian transfer. Hum. Reprod. 2002, 17:1746-1754.
69. Lacroix R., Eason E., Melzack R. Nausea and vomiting during pregnancy: A prospective study of its frequency, intensity, and patterns of change. Am. J. Obstet. Gynecol. 2000, 182:931-937.
70. Lampe J., King I., Li S., Grate M., Barale K., Chen C., Feng Z., Potter J.D. Brassica vegetables increase and apiaceous vegetables decrease cytochrome P450 1A2 activity in humans, changes in caffeine metabolic ratios in response to controlled vegetable diets. Carcinogenesis 2000, 21:1157-1162.
71. Lawson C.C., LeMasters G.K. Regarding " Caffeine metabolism, genetics and perinatal outcomes: a review of exposure assessment considerations during pregnancy" Ann. Epidemiol. 2006, 16:733.
72. Lawson C.C., LeMasters G.K., Levin L.S., Liu J.H. Pregnancy hormone metabolite patterns, pregnancy symptoms, and coffee consumption. Am. J. Epidemiol. 2002, 156:428-437.
73. Lawson C.C., LeMasters G.K., Wilson K.A. Changes in caffeine consumption as a signal of pregnancy. Reprod. Toxicol. 2004, 18:625-633.
74. Leviton A. Single-cause attribution. Dev. Med. Child Neurol. 1987, 29:805-807.
75. Leviton A., Cowan L. A review of the literature relating caffeine consumption by women to their risk of reproductive hazards. Food Chem. Toxicol. 2002, 40:1271-1310.
76. Li D.-K., Weng X.P., Odouli R. Reply to caffeine and miscarriage: case closed?. Am. J. Obstet. Gynecol. 2008, 199:e13-e14.
77. Lieff S., Olshan A.F., Werler M., Savitz D.A., Mitchell A.A. Selection bias and the use of controls with malformations in case-control studies of birth defects. Epidemiology 1999, 10:238-241.
78. Lindqvist R., Lendahls L., Tollbom O., Aberg H., Håkansson A. Smoking during pregnancy, a comparison of self-reports and cotinine levels in 496 women. Acta Obstet. Gynecol. Scand. 2002, 81:240-244.
79. Louik C., Hernandez-Diaz S., Werler M.M., Mitchell A.A. Nausea and vomiting in pregnancy, maternal characteristics and risk factors. Paediatr. Perinat. Epidemiol. 2006, 20:270-278.
80. Lynch, C.D., Zhang, J., 2007. The research implications of the selection of a gestational age estimation method. Paediatr. Perinat. Epidemiol. 21 (Suppl. 2), 86-96.
81. Maconochie N., Doyle P., Prior S., Simmons R. Risk factors for first trimester miscarriage - results from a UK-population-based case-control study. Br. J. Obstet. Gynaecol. 2007, 114:170-186.
82. Matijasevich A., Barros F.C., Santos I.S., Yemini A. Maternal caffeine consumption and fetal death, a case-control study in Uruguay. Paediatr. Perinat. Epidemiol. 2006, 20:100-109.
83. McElrath T.F., Hecht J.L., Dammann O., Boggess K., Onderdonk A., Markenson G., Harper M., Delpapa E., Allred E.N., Leviton A. Pregnancy disorders that lead to delivery before the 28th week of gestation, an epidemiologic approach to classification. Am. J. Epidemiol. 2008, 168:980-989. ELGAN Study Investigators.
84. Mikkelsen T.B., Osterdal M.L., Knudsen V.K., Haugen M., Meltzer H.M., Bakketeig L., Olsen S.F. Association between a Mediterranean-type diet and risk of preterm birth among Danish women, a prospective cohort study. Acta Obstet. Gynecol. Scand. 2008, 87:325-330.
85. Miller E.A., Manning S.E., Rasmussen S.A., Reefhuis J., Honein M.A. Maternal exposure to tobacco smoke, alcohol and caffeine, and risk of anorectal atresia, National Birth Defects Prevention Study 1997-2003. Paediatr. Perinat. Epidemiol. 2009, 23:9-17. The National Birth Defects Prevention Study.
86. Mongraw-Chaffin M.L., Cohn B.A., Cohen R.D., Christianson R.E. Maternal smoking, alcohol consumption, and caffeine consumption during pregnancy in relation to a son's risk of persistent cryptorchidism, a prospective study in the Child Health and Development Studies cohort, 1959-1967. Am. J. Epidemiol. 2008, 167:257-261.
87. Morrison A.S. Control of cigarette smoking in evaluating the association of coffee drinking and bladder cancer. Banbury Report 17; Coffee and Health 1984, 127-134. Cold Spring Harbor Laboratory, USA. B. MacMahon, T. Subimura (Eds.).
88. Naeye R.L. Do placental weights have clinical significance?. Hum. Pathol. 1987, 18:387-391.
89. Natsume N., Kawai T., Ogi N., Yoshida W. Maternal risk factors in cleft lip and palate, case control study. Br. J. Oral Maxillofac. Surg. 2000, 38:23-25.
90. Nebert D.W., McKinnon R.A., Puga A. Human drug-metabolizing enzyme polymorphisms, effects on risk of toxicity and cancer. DNA Cell Biol. 1996, 15:273-280.
91. Nordmark A., Lundgren S., Cnattingius S., Rane A. Dietary caffeine as a probe agent for assessment of cytochromone P4501A2 activity in random urine samples. Br. J. Clin. Pharmacol. 1999, 47:397-402.
92. Nussey S.S., Whitehead S.A. Endocrinology, An Integrated Approach 2001, Taylor and Francis, Oxford, UK.
93. Okon M.A., Laird S.M., Tuckerman E.M., Li T.C. Serum androgen levels in women who have recurrent miscarriages and their correlation with markers of endometrial function. Fertil. Steril. 1998, 69:682-690.
94. Ørskou J., Henriksen T.B., Kesmodel U., Secher N.J. Maternal characteristics and lifestyle factors and the risk of delivering high birth weight infants. Obstet. Gynecol. 2003, 102:115-120.
95. Ott W.J. Sonographic diagnosis of fetal growth restriction. Clin. Obstet. Gynecol. 2006, 49:295-307.
96. Parazzini F., Chiaffarino F., Chatenoud L., Tozzi L., Cipriani S., Chiantera V., Fedele L. Maternal coffee drinking in pregnancy and risk of small for gestational age birth. Eur. J. Clin. Nutr. 2005, 59:299-301.
97. Pennell, C.E., Jacobsson, B., Williams, S.M., Buus, R.M., Muglia, L.J., Dolan, S.M., Morken, N.H., Ozcelik, H., Lye, S.J. PREBIC Genetics Working Group, Relton, C., 2007. Genetic epidemiological studies of preterm birth, guidelines for research. Am. J. Obstet. Gynecol. 196, 107-118.
98. Piipari R., Savela K., Nurminen T., Hukkanen J., Raunio H., Hakkola J., Mäntylä T., Beaune P., Edwards R.J., Boobis A.R., Anttila S. Expression of CYP1A1, CYP1B1, CYP3A, and polycyclic aromatic hydrocarbon-DNA adduct formation in bronchoalveolar macrophages of smokers and non-smokers. Int. J. Cancer 2000, 86:610-616.
99. Ramlau-Hansen C.H., Thulstrup A.M., Bonde J.P., Olsen J., Bech B.H. Semen quality according to prenatal coffee and present caffeine exposure, two decades of follow-up of a pregnancy cohort. Hum. Reprod. 2008, 23:2799-2805.
100. Rasch V. Cigarette, alcohol, and caffeine consumption, risk factors for spontaneous abortion. Acta Obstet. Gynecol. Scand. 2003, 82:182-188.
101. Redline R.W., Patterson P. Patterns of placental injury correlations with gestational age, placental weight, and clinical diagnoses. Arch. Pathol. Lab. Med. 1994, 118:698-701.
102. Rotondi M., Valenzano F., Bilancioni E., Spano G., Rogonid M., Giorlandion C. Prenatal measurement of testicular diameter by ultrasonography, development of fetal male gender and evaluation of testicular descent. Prenat. Diagn. 2001, 21:112-115.
103. Sachse C., Brockmoller J., Bauer S., Roots I. Functional significance of a C→a polymorphism in intron 1 of the cytochromone P450 CYP1A2 gene tested with caffeine. Br. J. Clin. Pharmacol. 1999, 47:445-449.
104. Saltvedt S., Almström H., Kublickas M., Reilly M., Valentin L., Grunewald C. Ultrasound dating at 12-14 or 15-20weeks of gestation? A prospective cross-validation of established dating formulae in a population of in-vitro fertilized pregnancies randomized to early or late dating scan. Ultrasound Obstet. Gynecol. 2004, 24:42-50.
105. Santos I.S., Victora C.G., Huttly S., Carvalhal J.B. Caffeine intake and low birth weight, a population-based case-control study. Am. J. Epidemiol. 1998, 147:620-627.
106. Santos I.S., Matijasevich A., Valle N.C.J. Mate drinking during pregnancy and risk of preterm and small for gestational age birth. J. Nutr. 2005, 135:1120-1123.
107. Sata F., Yamada H., Suzuki K., Saijo Y., Kato E.H., Morikawa M., Minakami H., Kishi R. Caffeine intake, CYP1A2 polymorphism and the risk of recurrent pregnancy loss. Mol. Hum. Reprod. 2005, 11:357-360.
108. Savitz D.A. Disaggregating preterm birth to determine etiology. Am. J. Epidemiol. 2008, 68:990-992.
109. Savitz D.A., Blackmore C.A., Thorp J.M. Epidemiology of preterm delivery, etiologic heterogeneity. Am. J. Obstet. Gynecol. 1991, 164:467-471.
110. Savitz D.A., Hertz-Picciotto I., Poole C., Olsham A.F. Epidemiologic measures of the course and outcome of pregnancy. Epidemiol. Rev. 2002, 24:91-101.
111. Savitz D.A., Dole N., Herring A.M., Kaczor D., Murphy J., Siega-Riz A.M., Thorp J.M., MacDonald T.L. Should spontaneous and medically indicated preterm births be separated for studying aetiology?. Paediatr. Perinat. Epidemiol. 2005, 19:97-105.
112. Savitz D.A., Chan R.L., Herring A.H., Howards P.P., Hartmann K.E. Caffeine and miscarriage risk. Epidemiology 2008, 19:55-62.
113. Schlesselman J.J. Case Control Studies Design Conduct, Analysis 1982, Oxford University Press, New York, pp. 135-136.
114. Schmid T.E., Eskenazi B., Baumgartner A., Marchetti F., Young S., Weldon R., Anderson D., Wyrobek A.J. The effects of male age on sperm DNA damage in healthy non-smokers. Hum. Reprod. 2007, 22:180-187.
115. Schmidt, R.J., Romitti, P.A., Burns, T.L., Browne, M.L., Druschel, C.M., Olney, R.S., and the National Birth Defects Prevention Study, 2009. Maternal caffeine consumption and risk of neural tube defects. Birth Defects Res. A Clin. Mol. Teratol. 85, 879-889.
116. Schreiber G.B., Robins M., Maffeo C.E., Masters M.N., Bond A.P., Morganstein D. Confounders contributing to the reported associations of coffee or caffeine with disease. Prev. Med. 1988, 17:295-309.
117. Shimada T., Watanabe J., Kawajiri K., Sutter T.R., Guengerich F.P., Gillam E.M., Inoue K. Catalytic properties of polymorphic human cytochrome P450 1B1 variants. Carcinogenesis 1999, 20:1607-1613.
118. Signorello L.B., McLaughlin J.K. Maternal caffeine consumption and spontaneous abortion, a review of the epidemiologic evidence. Epidemiology 2004, 15:229-239.
119. Signorello L.B., Nordmark A., Granath F., Blot W.J., McLaughlin J.K., Annerén G., Lundgren S., Ekbom A., Rane A., Cnattingius S. Caffeine metabolism and the risk of spontaneous abortion of normal karyotype fetuses. Obstet. Gynecol. 2001, 98:1059-1066.
120. Simpson J.L. Incidence and timing of pregnancy losses, relevance to evaluating safety and early prenatal diagnosis. Am. J. Med. Genet. 1990, 35:165-173.
121. Slickers, J.E., Olshan, A.F., Siega-Riz, A.M., Honein, M.A., Aylsworth, A.S., for the National Birth Defects Prevention Study, 2008. Maternal body mass index and lifestyle exposures and the risk of bilateral renal agenesis or hypoplasia: The National Birth Defects Prevention Study. Am. J. Epidemiol. 168, 1259-1267.
122. Smith G.C. First trimester origins of fetal growth impairment. Semin. Perinatol. 2004, 28:41-50.
123. Smith G.C., Smith M.F., McNay M.B., Fleming J.E. First-trimester growth and the risk of low birth weight. N. Engl. J. Med. 1998, 339:1817-1822.
124. Sobreiro B.P., Lucon A.M., Pasqualotto F.F., Hallak J., Athayde K.S., Arap S. Semen analysis in fertile patients undergoing vasectomy, reference values and variations according to age, length of sexual abstinence, seasonality, smoking habits and caffeine intake. Sao Paulo Med. J. 2005, 123:161-166.
125. Spira A. The use of fecundability in epidemiological surveys. Hum. Reprod. 1998, 13:1753-1756.
126. Stein Z., Susser M. Miscarriage, caffeine and the epiphenomena of pregnancy, the causal model. Epidemiology 1991, 2:163-167.
127. Tan P.C., Jacob R., Quek K.F., Omar S.Z. The fetal sex ratio and metabolic, biochemical, haematological and clinical indicators of severity of hyperemesis gravidarum. Br. J. Obstet. Gynaecol. 2006, 113:733-737.
128. Thame M., Osmond C., Bennett F., Wilks R., Forrester T. Fetal growth is directly related to maternal anthropometry and placental volume. Eur. J. Clin. Nutr. 2004, 58:894-900.
129. Tingen C., Stanford J.B., Dunson D.B. Methodologic and statistical approaches to studying human fertility and environmental exposure. Environ. Health Perspect. 2004, 112:87-93.
130. Tolstrup J.S., Kjaer S.K., Munk C., Madsen L.B., Ottesen B., Bergholt T., Grønbaek M. Does caffeine and alcohol intake before pregnancy predict the occurrence of spontaneous abortion?. Hum. Reprod. 2003, 18:2704-2710.
131. Torfs C.P., Christianson R.E. Effect of maternal smoking and coffee consumption on the risk of having a recognized Down syndrome pregnancy. Am. J. Epidemiol. 2000, 152:1185-1191.
132. Tough S.C., Newburn-Cook C.V., White D.E., Fraser-Lee M.J., Faber A.J., Frick C., Svenson L.W., Sauve R. Do maternal characteristics and past pregnancy experiences predict preterm delivery among women aged 20-34?. J. Obstet. Gynaecol. Can. 2003, 25:656-666.
133. Tsubouchi H., Shimoya K., Hayashi S., Toda M., Morimoto K., Murata Y. Effect of coffee intake on blood flow and maternal stress during the third trimester of pregnancy. Int. J. Gynaecol. Obstet. 2006, 92:19-22.
134. Vik T., Vatten L., Markestad T., Jacobsen G., Bakketeig L.S. Dubowitz assessment of gestational age and agreement with prenatal methods. Am. J. Perinatol. 1997, 14:369-373.
135. Vik T., Bakketeig L.S., Trygg K.U., Lund-Larsen K., Jacobsen G. High caffeine consumption in the third trimester of pregnancy, gender-specific effects on fetal growth. Paediatr. Perinat. Epidemiol. 2003, 17:324-331.
136. Virtanen H.E., Tapanainen A.E., Kaleva M.M., Suomi A.M., Main K.M., Skakkebaek M.E., Toppari J. Mild gestational diabetes as a risk factor for congenital cryptorchidism. J. Clin. Endocrinol. Metab. 2006, 91:4862-4865.
137. Weigel R.M., Weigel M.M. Nausea and vomiting of early pregnancy and pregnancy outcome, a meta-analytical review. Br. J. Obstet. Gynaecol. 1989, 96:1312-1318.
138. Weigel M.M., Reyes M., Caiza M.E., Tello N., Castro N.P., Cespededs S., Duchicela S., Betancourt M. In the nausea and vomiting of early pregnancy really feto-protective?. J. Perinat. Med. 2006, 34:115-122.
139. Weinberg C.R., Hertz-Picciotto I., Baird D.D., Wilcox A.J. Efficiency and bias in studies of early pregnancy loss. Epidemiology 1992, 3:17-22.
140. Wen W., Xiao U.S., Jacobs D.R., Brown J.E. The associations of maternal caffeine consumption and nausea with spontaneous abortion. Epidemiology 2001, 12:38-42.
141. Weng X., Odouli R., Li D.K. Maternal caffeine consumption during pregnancy and the risk of miscarriage, a prospective cohort study. Am. J. Obstet. Gynecol. 2008, 198:279-286.
142. Wilcox A.J., Baird D.D., Weinberg C.R. Time of implantation of the conceptus and loss of pregnancy. N. Engl. J. Med. 1999, 340:1796-1799.
143. Wisborg K., Kesmodel U., Bech B.H., Hedegaard M., Henriksen T.B. Maternal consumption of coffee during pregnancy and stillbirth and infant death in first year of life, prospective study. BMJ 2003, 326:420-423.
144. Xue F., Willett W.C., Rosner B.A., Forman M.R., Michels K.B. Parental characteristics as predictors of birthweight. Hum. Reprod. 2008, 23:168-177.
145. Yoon H., Chung I.S., Seol E.Y., Park B.Y., Park H.W. Development of the lip and palate in staged human embryos and early fetuses. Yonsei Med. J. 2000, 41:477-484.
146. Yusuf R.Z., Naeem R. Cytogenic abnormalities in products of conception, a relationship revisited. Am. J. Reprod. Immunol. 2004, 52:88-96.
147. Zavela K.J., Barnett J.E., Smedi K.J., Istvan J.A., Matarazzo J.D. Concurrent use of cigarettes, alcohol and coffee. J. Appl. Soc. Psychol. 1990, 20:835-845.
148. Zhang X., Platt R.W., Cnattingius S., Joseph K.S., Kramer M.S. The use of customised versus population-based birthweight standards in predicting perinatal mortality. Br. J. Obstet. Gynaecol. 2007, 114:474-477.
149. Zusterzeel P.L., Nelen W.L., Roelofs H.M., Peters W.H., Blom H.J., Steegers E.A. Polymorphisms in biotransformation enzymes and the risk for recurrent early pregnancy loss. Mol. Hum. Reprod. 2000, 6:474-478.